GB0504501D0 - Liquids containing suspended glass particles - Google Patents

Liquids containing suspended glass particles

Info

Publication number
GB0504501D0
GB0504501D0 GBGB0504501.8A GB0504501A GB0504501D0 GB 0504501 D0 GB0504501 D0 GB 0504501D0 GB 0504501 A GB0504501 A GB 0504501A GB 0504501 D0 GB0504501 D0 GB 0504501D0
Authority
GB
United Kingdom
Prior art keywords
glass particles
liquids containing
particles
containing suspended
suspended glass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0504501.8A
Other versions
GB2413075B (en
GB2413075A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Biostability Ltd
Original Assignee
Cambridge Biostability Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Biostability Ltd filed Critical Cambridge Biostability Ltd
Priority to CN2005800110373A priority Critical patent/CN1942171B/en
Priority to AU2005232441A priority patent/AU2005232441B2/en
Priority to ES05731023T priority patent/ES2339783T3/en
Priority to PT05731023T priority patent/PT1750668E/en
Priority to MXPA06011895A priority patent/MXPA06011895A/en
Priority to PCT/GB2005/050050 priority patent/WO2005099669A1/en
Priority to CA002562606A priority patent/CA2562606A1/en
Priority to AT05731023T priority patent/ATE457717T1/en
Priority to US10/599,928 priority patent/US20080026066A1/en
Publication of GB0504501D0 publication Critical patent/GB0504501D0/en
Priority to RU2006137275/15A priority patent/RU2363447C2/en
Priority to DE602005019398T priority patent/DE602005019398D1/en
Priority to KR1020067022106A priority patent/KR20070009639A/en
Priority to EP05731023A priority patent/EP1750668B1/en
Priority to JP2007507853A priority patent/JP2007532619A/en
Priority to DK05731023.7T priority patent/DK1750668T3/en
Publication of GB2413075A publication Critical patent/GB2413075A/en
Application granted granted Critical
Publication of GB2413075B publication Critical patent/GB2413075B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Glass Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A pharmaceutical composition comprising a biologically active agent preserved in particulate form, in particular a glass or amorphous particle, such as a sugar, a metal carboxylate, an amino acid or calcium phosphate, wherein said particles are suspended in at least one of a hydrofluoroether, a perfluoroether, a hydrofluoroamine, a perfluoroamine, a hydrofluorothioether, a perfluorothioether, a hydrofluoropolyether or a perfluoropolyether. The use of such fluorinated liquid media overcomes the problem of aggregation of particles and also is environmentally friendly.
GB0504501A 2004-04-13 2005-03-07 Liquids containing suspended glass particles Active GB2413075B (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
DE602005019398T DE602005019398D1 (en) 2004-04-13 2005-04-13 LIQUIDS WITH SUSPENDED GLASS PARTICLES
RU2006137275/15A RU2363447C2 (en) 2004-04-13 2005-04-13 Liquid, containing suspended vitreous particles
KR1020067022106A KR20070009639A (en) 2004-04-13 2005-04-13 Liquids containing suspended glass particles
AU2005232441A AU2005232441B2 (en) 2004-04-13 2005-04-13 Liquids containing suspended glass particles
PCT/GB2005/050050 WO2005099669A1 (en) 2004-04-13 2005-04-13 Liquids containing suspended glass particles
CA002562606A CA2562606A1 (en) 2004-04-13 2005-04-13 Liquids containing suspended glass particles
AT05731023T ATE457717T1 (en) 2004-04-13 2005-04-13 LIQUIDS WITH SUSPENDED GLASS PARTICLES
US10/599,928 US20080026066A1 (en) 2004-04-13 2005-04-13 Liquids Containing Suspended Glass Particles
CN2005800110373A CN1942171B (en) 2004-04-13 2005-04-13 Liquids containing suspended glass particles
ES05731023T ES2339783T3 (en) 2004-04-13 2005-04-13 LIQUIDS CONTAINING SUSTAINED VITREAS PARTICLES.
MXPA06011895A MXPA06011895A (en) 2004-04-13 2005-04-13 Liquids containing suspended glass particles.
PT05731023T PT1750668E (en) 2004-04-13 2005-04-13 Liquids containing suspended glass particles
EP05731023A EP1750668B1 (en) 2004-04-13 2005-04-13 Liquids containing suspended glass particles
JP2007507853A JP2007532619A (en) 2004-04-13 2005-04-13 Liquid containing suspended glass particles
DK05731023.7T DK1750668T3 (en) 2004-04-13 2005-04-13 Liquids containing suspended glass particles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0408199.8A GB0408199D0 (en) 2004-04-13 2004-04-13 Liquids containing suspended sugar glass particles

Publications (3)

Publication Number Publication Date
GB0504501D0 true GB0504501D0 (en) 2005-04-13
GB2413075A GB2413075A (en) 2005-10-19
GB2413075B GB2413075B (en) 2009-01-21

Family

ID=32320732

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0408199.8A Ceased GB0408199D0 (en) 2004-04-13 2004-04-13 Liquids containing suspended sugar glass particles
GB0504501A Active GB2413075B (en) 2004-04-13 2005-03-07 Liquids containing suspended glass particles

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB0408199.8A Ceased GB0408199D0 (en) 2004-04-13 2004-04-13 Liquids containing suspended sugar glass particles

Country Status (10)

Country Link
CN (1) CN1942171B (en)
AT (1) ATE457717T1 (en)
DE (1) DE602005019398D1 (en)
DK (1) DK1750668T3 (en)
ES (1) ES2339783T3 (en)
GB (2) GB0408199D0 (en)
MX (1) MXPA06011895A (en)
PT (1) PT1750668E (en)
RU (1) RU2363447C2 (en)
ZA (1) ZA200609158B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0517688D0 (en) * 2005-08-31 2005-10-05 Cambridge Biostability Ltd Improvements in the stabilisation of biological materials
GB0523638D0 (en) 2005-11-21 2005-12-28 Cambridge Biostability Ltd Pharmaceutical device for the administration of substances to patients
US9243626B2 (en) * 2012-11-19 2016-01-26 Nordson Corporation Adhesive dispensing system and method including a pump with integrated diagnostics

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07258027A (en) * 1994-03-16 1995-10-09 Shiseido Co Ltd Makeup cosmetic
US6433040B1 (en) * 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6190701B1 (en) * 1999-03-17 2001-02-20 Peter M. Ronai Composition and method for stable injectable liquids
WO2001037804A2 (en) * 1999-11-22 2001-05-31 Universal Preservation Technologies, Inc. Preservation and formulation of bioactive materials
JP2004513093A (en) * 2000-10-13 2004-04-30 ケンブリッジ、バイオスタビリティー、リミテッド Compositions and methods for stable injections

Also Published As

Publication number Publication date
CN1942171A (en) 2007-04-04
ES2339783T3 (en) 2010-05-25
GB0408199D0 (en) 2004-05-19
ZA200609158B (en) 2008-06-25
DK1750668T3 (en) 2010-05-10
RU2006137275A (en) 2008-05-20
MXPA06011895A (en) 2007-11-20
PT1750668E (en) 2010-04-07
GB2413075B (en) 2009-01-21
DE602005019398D1 (en) 2010-04-01
RU2363447C2 (en) 2009-08-10
GB2413075A (en) 2005-10-19
ATE457717T1 (en) 2010-03-15
CN1942171B (en) 2011-04-06

Similar Documents

Publication Publication Date Title
EP2335575A3 (en) Magnetic gas bubble composition and magnetic gas bubble precursor for its manufacture
HK1135609A1 (en) Formation of medically useful gels comprising microporous particles and methods of use
GB2464038A (en) System, method, and apparatus for combined fracturing treatment and scale inhibition
WO2004058156A3 (en) High pressure spray-dry of bioactive materials
CO5660273A2 (en) PROTEIN AND HIGH CONCENTRATION ANTIBODY FORMULATIONS
DE502005009045D1 (en) MAGNETORHEOLOGICAL MATERIALS WITH HIGH SWITCHING FACTOR AND ITS USE
MX271467B (en) Personal cleansing composition containing irregularly shaped particles and spherical particles.
DE502004007577D1 (en) Lymerpartikel
WO2006137934A3 (en) Purposeful movement of human migratory cells away from an agent source
HK1069994A1 (en) Powder processing with pressurized gaseous fluids
TW200602368A (en) Particulate water absorbing agent with water-absorbing resin as main component
PL2007863T3 (en) Granulates for a sensitive washing- or cleaning agent containing material
WO2006036684A3 (en) Fishcher-tropsch wax composition and method of transport
EP4218718A3 (en) Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
NL1030058A1 (en) Fischer-Tropsch wax composition and mode of transport.
WO2007111681A3 (en) Device and methods for liquid crystal-based bioagent detection
GB2413075B (en) Liquids containing suspended glass particles
EA200701884A1 (en) FOOD LIPID COMPOSITION IN THE FORM OF PARTICLES
WO2007082155A3 (en) Molecules with complexing groups for aqueous nanoparticle dispersions and uses thereof
UA96145C2 (en) Fat-containing composition and method for improving solubility of fat-containing powders in cold liquids
HK1146386A1 (en) Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes
WO2009060608A1 (en) Sustained release composition containing sdf-1
EP2511306A3 (en) Catalyst with low surface area
TR200102988T2 (en) Absorbents for use in handling complex liquids.
De Leon-Oliva et al. Advanced Hydrogel-Based Strategies for Enhanced Bone and Cartilage Regeneration: A Comprehensive Review

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)

Free format text: REGISTERED BETWEEN 20090709 AND 20090715

732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)

Free format text: REGISTERED BETWEEN 20091203 AND 20091209

S73 Revocation on comptroller's initiative (section 73/patents act 1977)

Free format text: PATENT REVOKED; PATENT REVOKED UNDER SECTION 73(2) ON 22 JUNE 2011